Visian ICL (Implantable Collamer Lens) stands out in ophthalmology as a revolutionary treatment for severe myopia. Unlike traditional laser procedures, Visian ICL involves implanting a specialized lens between the iris and natural lens of the eye, offering exceptional visual correction without altering the corneal tissue. This makes it particularly suitable for patients with thin corneas or high refractive errors who are not ideal candidates for LASIK. The procedure is minimally invasive, and recovery is rapid, with many patients experiencing improved vision immediately. Visian ICL provides high-definition vision, enhancing contrast sensitivity and reducing glare, which contributes to a superior visual experience. Its biocompatible material ensures long-term comfort and safety inside the eye. Continued advancements in Visian ICL technology promise even better outcomes, solidifying its place as a leading option for those seeking reliable, effective, and safe vision correction beyond traditional methods like glasses or contact lenses.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom